Gilead Sciences (GILD) Long-Term Investments (2009 - 2026)
Gilead Sciences' Long-Term Investments came in at $983 million for Q1 2026, down 66.9% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Long-Term Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences' Long-Term Investments was $2.97 billion.
- Long-Term Investments carries a five-year compound annual growth rate of 42.7% (FY2020 to FY2025).
- Going back by year, Long-Term Investments was $1.16 billion in FY2023 (-6.6%), $1.25 billion in FY2022 (-4.9%) and $1.31 billion in FY2021 (+160.8%).
- The Q1 2026 figure represents the lowest quarterly Long-Term Investments since Q2 2021.
- The fastest year-over-year change in Long-Term Investments over five years came in Q4 2021 (growth of 160.8%), and the weakest in Q2 2021 (a decline of 63.3%).
- Business Quant data shows GILD's Long-Term Investments at $2.97 billion (Q4 2025), $2.01 billion (Q3 2025) and $1.91 billion (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 5.79 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 983.00 Mn |
| Dec 31, 2025 | 2.97 Bn |
| Sep 30, 2025 | 2.01 Bn |
| Jun 30, 2025 | 1.91 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 1.16 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 1.33 Bn |
| Dec 31, 2022 | 1.25 Bn |
| Sep 30, 2022 | 1.28 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Mar 31, 2022 | 1.43 Bn |
| Dec 31, 2021 | 1.31 Bn |
| Sep 30, 2021 | 1.10 Bn |
| Jun 30, 2021 | 836.00 Mn |
| Mar 31, 2021 | 579.00 Mn |
| Dec 31, 2020 | 502.00 Mn |
| Sep 30, 2020 | 2.07 Bn |
| Jun 30, 2020 | 2.28 Bn |
| Mar 31, 2020 | 3.53 Bn |
API Access
Gilead Sciences Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();